CME Group receives CMA clearance for proposed NEX acquisition
Derivatives marketplace CME Group (NASDAQ:CME) and NEX Group (LON:NXG) have announced they have received clearance from the UK Competition and Markets Authority for CME Group's proposed acquisition of NEX. Completion of the transaction remains subject to sanction by the UK Court. The parties have scheduled the court hearing for November 1, 2018 and expect the closing to…
Read more